Felipe Osório
Psychiatrist and Clinical Researcher
Data updated
Papers
Trials
Research Footprint
Felipe Osório appears in 15 tracked papers (2015–2023), most studied alongside Ayahuasca, Psilocybin and LSD, across Depressive Disorders, Anxiety Disorders and Healthy Volunteers.
Most-cited paper: Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (814 citations).
Frequent co-authors: Rafael dos Santos, Jamie Hallak and Jaime Crippa.
Background & Research
Felipe L. Osório is a clinician-researcher who has contributed substantially to contemporary clinical research on serotonergic psychedelics, with a particular focus on ayahuasca and its effects in mood and anxiety disorders. Using a mixed-methods approach that includes randomised, placebo-controlled proof-of-concept trials, SPECT neuroimaging, and qualitative long-term follow-up, he has helped to characterise both acute antidepressant and anxiolytic effects and the persistence of therapeutic outcomes in people with recurrent depression and social anxiety. Osório is also a frequent co-author on reviews synthesising historical, pharmacological and therapeutic evidence for ayahuasca and related classic hallucinogens, advancing methodological transparency and integration of neurobiological and phenomenological data in the field.
Key Impact
Notable for clinical and translational research on ayahuasca's therapeutic potential in mood and anxiety disorders, including early randomized and neuroimaging studies and longer-term follow-ups.
Collaboration Network
18 collaborators· click a node to visit their profile
Full network →